Introduction
Vitamin D deficiency is a major concern worldwide. It has been estimated that almost one billion people in the world suffer from vitamin D deficiency or insufficiency. 1 Even in tropical regions where the risk of vitamin D deficiency was previously assumed to be low, has become a global public health concern nowa-days. 2 Even a study shows that deficiency in vitamin D is observed in Bangladesh female garment workers. 3 Much evidence have suggested that vitamin D deficiency is involved in the development of various diseases including type 1 and type 2 diabetes, 4 cardiovascular disease, 5 cancer 6 and autoimmune diseases. 7 In fact, in addition to its classical role in bone and mineral homeostasis, recent studies have shown that vitamin D has inhibitory effects on inflammation and proliferation of endothelial cells and angiogenesis which are involved in the development of diabetic retinopathy. 8, 9 The cause of diabetic retinopathy is not clear. The retinopathy may develop not only in diabetes but also in neonate. 10 Several studies have also shown that vitamin D receptor is expressed in retina and vitamin D has direct inhibitory effects on the development of diabetic retinopathy in experimental animal models. Some studies revealed that vitamin D inhibits retinal neovascularization in a mouse oxygen-induced ischemic retinopathy model. 11, 12 Further studies revealed that vitamin D has protective effects on diabetic retinopathy by inhibiting vascular endothelial growth factor (VEGF) and transforming growth factor-β1 (TGF-β1) in the retinas of diabetic rats. 13 In addition, some human genetic studies have shown that polymorphisms of vitamin D receptor gene are associated with diabetic retinopathy. 14, 15 All these suggest a role of vitamin D in the pathogenesis of the development of diabetic retinopathy.
Vitamin D deficiency may also be associated with a high plasma parathormone level, subsequently which may present in subretinal fluid of the human eye. It is shown through different studies that parathormone excess can reduce glucose tolerance 16 and induce inflammatory cytokines like IL-6 and its soluble receptor (IL-6sR) 17 and thereby may contribute to development and progression of diabetic retinopathy.
The potential role of vitamin D deficiency and associated high parathormone in the development of diabetic retinopathy has been a matter of specific interest in recent years. That is why, we designed a study which was aimed to evaluate the association of serum vitamin D and 
Materials and Methods

Results
There were no significant differences among groups in terms of overall baseline demographic, paraclinical and clinical characteristics ( Table I ).
The concentration of serum vitamin D (in ng/mL) differed significantly among groups (p=0.018) and it was significantly lower in proliferative retinopathy group compared to non-retinopathy group (p=0.003). However, the concentration of parathormone among groups did not differ significantly (p=0.752) (Table II) .
Spearman's correlation test revealed that there was a significant negative correlation between serum 62 BSMMU J 2017; 10: 61-65 (Table III) .
Discussion
This study was aimed to evaluate the association of serum vitamin D and parathormone concentrations with diabetic retinopathy in type 2 diabetic patients.
Serum vitamin D concentration differed significantly among groups and there was a downward trend in average vitamin D level with increased stages of diabetic retinopathy. The concentration was significantly lower in proliferative diabetic retinopathy group than no diabetic retinopathy group. However, the concentration of parathormone among three groups did not differ significantly. Alcubierre et al., 2015, 20 conducted a case-control study to explore the association of vitamin D and diabetic retinopathy. When the authors compared the biochemical characteristics of type 2 diabetic patients with and without retinopathy, they found lower level of vitamin D in retinopathy group than in no retinopathy group and it was significantly lower in Grade 2-4 DR group than no diabetic retinopathy group which were consistent with our findings. Similar to the findings of our study, the authors did not find any significant difference of parathormone level. He et al. (2014) and thus, conflicted with our study result. According to the study by Zoppini et al. (2015) , the multiple logistic regression analysis showed that there were significant association of high vitamin D with reduced risk of diabetic retinopathy and that of longer duration of diabetes with increased risk of diabetic retinopathy. The dissimilarities of these two study results with our study findings indicate that a multi-institutional large sample case-control study is needed to be conducted.
Conclusion
Vitamin D deficiency is independently associated with diabetic retinopathy in patients with type 2 diabetes mellitus. However, the relationship between vitamin D and parathormone and/or parathormone and diabetic retinopathy still remains inconclusive.
